Niklason Laura E, President, CEO and Director of Humacyte, Inc. ($HUMA), sold about $3.7 million in company shares through three open market transactions over the last 365 days, with her most recent sale on August 20, 2025. Her total sales rank 2347th among nearly 12,000 individual insiders, below the average of $8.6 million per seller and 6.4 transactions. She made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 16, 2025 | Humacyte, Inc. | $HUMA | Niklason Laura E | President, CEO and Director | A | Stock Options (right to buy) | 311100 | $0.00 | 311,100.0000 | 187,271,321 | 9999.99% | 0.17% |
| Aug. 20, 2025 | Humacyte, Inc. | $HUMA | Niklason Laura E | President, CEO and Director | S | Common Stock | 591685 | $1.58 | 1,392,091.0000 | 155,118,816 | 29.83% | 0.38% |
| Aug. 19, 2025 | Humacyte, Inc. | $HUMA | Niklason Laura E | President, CEO and Director | S | Common Stock | 1100000 | $1.63 | 1,983,776.0000 | 155,118,816 | 35.67% | 0.71% |
| Aug. 18, 2025 | Humacyte, Inc. | $HUMA | Niklason Laura E | President, CEO and Director | S | Common Stock | 549360 | $1.83 | 3,083,776.0000 | 155,118,816 | 15.12% | 0.35% |
| June 12, 2025 | Humacyte, Inc. | $HUMA | Niklason Laura E | President, CEO and Director | A | Stock Options (right to buy) | 0 | $0.00 | 0.0000 | 155,118,816 | 0.00% | 0.00% |
| Jan. 21, 2025 | Humacyte, Inc. | $HUMA | Niklason Laura E | President, CEO and Director | A | Stock Options (right to buy) | 1130311 | $0.00 | 1,130,311.0000 | 0 | 9999.99% | 0.00% |
| Dec. 19, 2024 | Humacyte, Inc. | $HUMA | Niklason Laura E | President, CEO and Director | A | Stock Options (right to buy) | 525 | $0.00 | 2,625.0000 | 0 | 25.00% | 0.00% |
| Nov. 19, 2024 | Humacyte, Inc. | $HUMA | Niklason Laura E | President, CEO and Director | P | Common Stock | 1797 | $4.44 | 3,633,136.0000 | 0 | 0.05% | 0.00% |
| Nov. 19, 2024 | Humacyte, Inc. | $HUMA | Niklason Laura E | President, CEO and Director | S | Common Stock | 427459 | $4.34 | 3,892,708.0000 | 0 | 9.89% | 0.00% |
| Nov. 20, 2024 | Humacyte, Inc. | $HUMA | Niklason Laura E | President, CEO and Director | S | Common Stock | 261369 | $4.40 | 3,631,339.0000 | 0 | 6.71% | 0.00% |
| Nov. 18, 2024 | Humacyte, Inc. | $HUMA | Niklason Laura E | President, CEO and Director | S | Common Stock | 811172 | $4.44 | 4,320,167.0000 | 0 | 15.81% | 0.00% |
| Sept. 10, 2024 | Humacyte, Inc. | $HUMA | Niklason Laura E | President, CEO and Director | S | Common Stock | 288674 | $5.23 | 5,131,339.0000 | 0 | 5.33% | 0.00% |
| Sept. 9, 2024 | Humacyte, Inc. | $HUMA | Niklason Laura E | President, CEO and Director | S | Common Stock | 157704 | $5.42 | 5,420,013.0000 | 0 | 2.83% | 0.00% |
| Aug. 29, 2024 | Humacyte, Inc. | $HUMA | Niklason Laura E | President, CEO and Director | P | Common Stock | 1222 | $6.55 | 5,577,717.0000 | 0 | 0.02% | 0.00% |
| Aug. 28, 2024 | Humacyte, Inc. | $HUMA | Niklason Laura E | President, CEO and Director | S | Common Stock | 277090 | $6.47 | 5,928,607.0000 | 0 | 4.47% | 0.00% |
| Aug. 29, 2024 | Humacyte, Inc. | $HUMA | Niklason Laura E | President, CEO and Director | S | Common Stock | 352112 | $6.35 | 5,576,495.0000 | 0 | 5.94% | 0.00% |
| Aug. 27, 2024 | Humacyte, Inc. | $HUMA | Niklason Laura E | President, CEO and Director | S | Common Stock | 252676 | $6.71 | 6,205,697.0000 | 0 | 3.91% | 0.00% |
| June 13, 2024 | Humacyte, Inc. | $HUMA | Niklason Laura E | President, CEO and Director | A | Stock Options (right to buy) | 50000 | $0.00 | 50,000.0000 | 0 | 9999.99% | 0.00% |
| June 11, 2024 | Humacyte, Inc. | $HUMA | Niklason Laura E | President, CEO and Director | S | Common Stock | 282000 | $7.09 | 6,806,521.0000 | 0 | 3.98% | 0.00% |
| June 11, 2024 | Humacyte, Inc. | $HUMA | Niklason Laura E | President, CEO and Director | S | Common Stock | 76630 | $7.02 | 6,729,891.0000 | 0 | 1.13% | 0.00% |
| June 12, 2024 | Humacyte, Inc. | $HUMA | Niklason Laura E | President, CEO and Director | S | Common Stock | 271518 | $7.30 | 6,458,373.0000 | 0 | 4.03% | 0.00% |
| June 4, 2024 | Humacyte, Inc. | $HUMA | Niklason Laura E | President, CEO and Director | P | Common Stock | 2362 | $6.35 | 7,088,521.0000 | 0 | 0.03% | 0.00% |
| May 31, 2024 | Humacyte, Inc. | $HUMA | Niklason Laura E | President, CEO and Director | S | Common Stock | 716573 | $7.78 | 7,371,438.0000 | 0 | 8.86% | 0.00% |
| May 31, 2024 | Humacyte, Inc. | $HUMA | Niklason Laura E | President, CEO and Director | S | Common Stock | 93213 | $8.93 | 7,278,225.0000 | 0 | 1.26% | 0.00% |
| June 3, 2024 | Humacyte, Inc. | $HUMA | Niklason Laura E | President, CEO and Director | S | Common Stock | 190214 | $7.42 | 7,088,011.0000 | 0 | 2.61% | 0.00% |
| June 4, 2024 | Humacyte, Inc. | $HUMA | Niklason Laura E | President, CEO and Director | S | Common Stock | 1852 | $7.28 | 7,086,159.0000 | 0 | 0.03% | 0.00% |
| June 3, 2024 | Humacyte, Inc. | $HUMA | Niklason Laura E | President, CEO and Director | P | Common Stock | 2050 | $7.37 | 8,088,011.0000 | 0 | 0.03% | 0.00% |
| Dec. 8, 2023 | Humacyte, Inc. | $HUMA | Niklason Laura E | President, CEO and Director | A | Stock Options (right to buy) | 803000 | $0.00 | 803,000.0000 | 0 | 9999.99% | 0.00% |
| Dec. 11, 2023 | Humacyte, Inc. | $HUMA | Niklason Laura E | President, CEO and Director | A | Stock Options (right to buy) | 525 | $0.00 | 2,100.0000 | 0 | 33.33% | 0.00% |
| Oct. 10, 2023 | Humacyte, Inc. | $HUMA | Niklason Laura E | President, CEO and Director | M | Common Stock | 114420 | $1.19 | 8,085,961.0000 | 0 | 1.44% | 0.00% |
| Oct. 10, 2023 | Humacyte, Inc. | $HUMA | Niklason Laura E | President, CEO and Director | M | Stock Options (right to buy) | 114420 | $0.00 | 48,176.0000 | 0 | 70.37% | 0.00% |
| Sept. 14, 2023 | Humacyte, Inc. | $HUMA | Niklason Laura E | President, CEO and Director | S | Common Stock | 2000000 | $2.78 | 7,971,541.0000 | 0 | 20.06% | 0.00% |
| Aug. 17, 2023 | Humacyte, Inc. | $HUMA | Niklason Laura E | President, CEO and Director | S | Common Stock | 570174 | $3.68 | 11,200,963.0000 | 0 | 4.84% | 0.00% |
| Aug. 18, 2023 | Humacyte, Inc. | $HUMA | Niklason Laura E | President, CEO and Director | S | Common Stock | 626979 | $3.57 | 10,573,984.0000 | 0 | 5.60% | 0.00% |
| Aug. 21, 2023 | Humacyte, Inc. | $HUMA | Niklason Laura E | President, CEO and Director | S | Common Stock | 602443 | $3.39 | 9,971,541.0000 | 0 | 5.70% | 0.00% |
| June 15, 2023 | Humacyte, Inc. | $HUMA | Niklason Laura E | President, CEO and Director | A | Stock Options (right to buy) | 8500 | $0.00 | 8,500.0000 | 0 | 9999.99% | 0.00% |
| June 15, 2023 | Humacyte, Inc. | $HUMA | Niklason Laura E | President, CEO and Director | S | Common Stock | 500000 | $3.12 | 11,771,137.0000 | 0 | 4.07% | 0.00% |
| June 13, 2023 | Humacyte, Inc. | $HUMA | Niklason Laura E | President, CEO and Director | S | Common Stock | 4875000 | $2.60 | 12,271,137.0000 | 0 | 28.43% | 0.00% |
| May 25, 2023 | Humacyte, Inc. | $HUMA | Niklason Laura E | President, CEO and Director | S | Common Stock | 2625000 | $2.75 | 17,146,137.0000 | 0 | 13.28% | 0.00% |
| March 1, 2023 | Humacyte, Inc. | $HUMA | Niklason Laura E | President, CEO and Director | M | Common Stock | 100000 | $1.19 | 19,771,137.0000 | 0 | 0.51% | 0.00% |
| March 1, 2023 | Humacyte, Inc. | $HUMA | Niklason Laura E | President, CEO and Director | M | Stock Options (right to buy) | 100000 | $0.00 | 162,596.0000 | 0 | 38.08% | 0.00% |